Page last updated: 2024-11-06

prednisolone and Hepatitis, Chronic

prednisolone has been researched along with Hepatitis, Chronic in 97 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Hepatitis, Chronic: INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.

Research Excerpts

ExcerptRelevanceReference
"Forty-one hepatitis B e antigen (HBeAg) and hepatitis B virus (HBV) DNA positive Chinese patients with chronic active hepatitis B were randomized to receive either prednisolone or placebo oral for 8 weeks."9.07A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B. ( Lee, SD; Lin, HC; Lo, KJ; Tong, MJ; Tsai, YT; Wu, JC, 1991)
"Twenty patients with hepatitis B e antigen (HBeAg) -positive chronic hepatitis, who received 40 mg of prednisolone per day for three weeks followed by withdrawal, were studied for changes in alanine aminotransferase (ALT), triiodothyronine (T3), thyroxine (T4), and hepatitis B virus DNA polymerase (HBV-DNAp) levels determined before and during prednisolone treatment and after its withdrawal."7.68Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal. ( Itoh, S; Marutani, K; Matsuo, S; Oda, T; Sasaki, K, 1990)
"Short-term prednisolone therapy was instituted on 27 patients with chronic active hepatitis (CAH) type B, in an attempt to induce seroconversion from hepatitis B e antigen (HBeAg) to the corresponding antibody (anti-HBe)."7.67Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B. ( Ikeda, K; Kojima, M; Kumada, H; Mayumi, M; Seto, S; Suzuki, H; Tsukada, T; Yoshida, A, 1987)
"In 1981, we initiated combination therapy of short-term prednisolone withdrawal and adenine arabinoside (ARA-A) or interferon (IF) for the treatment of chronic hepatitis B."7.67Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study. ( Omata, M; Uchiumi, K, 1986)
"In 42 patients with chronic active hepatitis (CAH), liver biopsies were subjected to histological study and morphometry before and after prednisolone treatment (21 patients comprising group I) and treatment with a complex of vitamins B1, B6, B12 and C (21 patients comprising group II)."6.66[Evaluation of therapeutic effectiveness of prednisolone in patients with chronic active hepatitis based on the morphometry of liver biopsy specimens]. ( Mansurov, KhKh; Mirodzhov, GK; Mishanina, ZG; Pavlov, VL, 1985)
"Prednisolone treatment normalized coagulopathies associated with chronic idiopathic hepatitis within one week in all 10 dogs that had coagulopathies at initial diagnosis."5.39A retrospective study of oral prednisolone treatment in canine chronic hepatitis. ( Favier, RP; Penning, LC; Poldervaart, JH; Rothuizen, J; van den Ingh, TS, 2013)
"To evaluate the effect of interferon and the benefit of prednisolone pretreatment in Oriental patients with chronic active hepatitis B, 120 male Chinese patients were randomly allocated to receive: 1) group A: a 4-week course of prednisolone followed by 2 weeks of no treatment and then a 12-week course of human lymphoblastoid interferon, 4 to 6 MU/m2 intramuscularly; 2) group B: as group A, but with placebo given instead of prednisolone; 3) group C: an 18-week course of placebo."5.07Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial. ( Chen, TJ; Chien, RN; Chu, CM; Liaw, YF; Lin, SM; Sheen, IS, 1994)
"Forty-one hepatitis B e antigen (HBeAg) and hepatitis B virus (HBV) DNA positive Chinese patients with chronic active hepatitis B were randomized to receive either prednisolone or placebo oral for 8 weeks."5.07A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B. ( Lee, SD; Lin, HC; Lo, KJ; Tong, MJ; Tsai, YT; Wu, JC, 1991)
"The efficacy of human lymphoblastoid interferon (Wellferon) therapy was measured in 20 children with chronic hepatitis B with or without pretreatment with prednisolone."5.06Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon. ( Barigione, G; Cirillo, C; Facco, F; Giacchino, R; Giambartolomei, G; Navone, C; Terragna, A; Timitilli, A, 1988)
" Immunosuppressive treatment with initially 60mg/d prednisolone improved the skin condition but activated the chronic hepatitis, GPT rising up to 240 U/l."3.69[Hepatitis-B-associated vasculitis. Clinical course with glucocorticoid and alpha-interferon therapy]. ( Glück, T; Weber, P; Wiedmann, KH, 1994)
"Twenty patients with hepatitis B e antigen (HBeAg) -positive chronic hepatitis, who received 40 mg of prednisolone per day for three weeks followed by withdrawal, were studied for changes in alanine aminotransferase (ALT), triiodothyronine (T3), thyroxine (T4), and hepatitis B virus DNA polymerase (HBV-DNAp) levels determined before and during prednisolone treatment and after its withdrawal."3.68Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal. ( Itoh, S; Marutani, K; Matsuo, S; Oda, T; Sasaki, K, 1990)
" A 40-year-old Japanese woman with antiphospholipid syndrome has been treated with prednisolone for two years since she was diagnosed as having a mixed type of chronic active hepatitis and primary biliary cirrhosis."3.68Mixed types of chronic active hepatitis and primary biliary cirrhosis associated with the anti-phospholipid antibody syndrome: a case report. ( Kaneko, S; Kawara, S; Kobayashi, K; Nakanuma, Y; Ogino, H; Saeki, R; Terasaki, S; Unoura, M; Wakabayashi, T, 1993)
"In 1981, we initiated combination therapy of short-term prednisolone withdrawal and adenine arabinoside (ARA-A) or interferon (IF) for the treatment of chronic hepatitis B."3.67Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study. ( Omata, M; Uchiumi, K, 1986)
"Changes in the host interferon system during short-term steroid hormone (prednisolone) withdrawal therapy in seven patients with HBeAg-positive chronic hepatitis B were investigated by estimating the in vitro interferon-alpha production in peripheral blood lymphocytes and 2-5 oligoadenylate synthetase activity in the serum."3.67Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy. ( Hashimoto, T; Hattori, N; Hinoue, Y; Hirai, N; Kobayashi, K; Morioka, T; Shimizu, M; Tanaka, N, 1988)
"Short-term prednisolone therapy was instituted on 27 patients with chronic active hepatitis (CAH) type B, in an attempt to induce seroconversion from hepatitis B e antigen (HBeAg) to the corresponding antibody (anti-HBe)."3.67Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B. ( Ikeda, K; Kojima, M; Kumada, H; Mayumi, M; Seto, S; Suzuki, H; Tsukada, T; Yoshida, A, 1987)
" A marked increase in spontaneous and pokeweed mitogen-induced proliferation of IgG producing cells was observed in 30 patients with untreated autoimmune CAH when compared with 25 normal subjects and 21 patients with autoimmune disease in whom a remission had been induced and maintained by prednisolone (P less than 0."3.67IgG production in 'autoimmune' chronic active hepatitis. Effect of prednisolone on T and B lymphocyte function. ( Alexander, GJ; Eddleston, AL; Hegarty, JE; Nouri-Aria, KT; Williams, R, 1985)
"A patient with long-standing filarial chyluria developed severe lymphocytopenia, extensive mucosal candidiasis and disseminated cryptococcosis when given small doses of prednisolone and azathioprine, for the treatment of a co-existing chronic active hepatitis."3.66Filarial chyluria with opportunistic infections. ( Chandy, M; Date, A; Pulimood, BM, 1983)
"Six patients with histologically proven HBsAg-negative chronic active hepatitis (CAH), who were initially treated successfully with prednisolone with or without azathioprine, developed unacceptable adverse effects due to prednisolone."2.67D-penicillamine therapy in patients with HBsAg-negative chronic active hepatitis and major prednisolone-induced adverse effects. ( Callender, ME; McClements, BM, 1990)
"Sixty patients with chronic active hepatitis B and positive serum HBV-DNA were randomized into two treatment groups (n = 20, respectively) and one control group (no treatment; n = 20)."2.67Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B. ( Heintges, T; Niederau, C; Niederau, M; Stremmel, W; Strohmeyer, G, 1992)
"Fifty-six patients with chronic active hepatitis (CAH) received immunosuppressive treatment (corticosteroids combined with azathioprine)."2.66HBeAg/anti-HBe seroconversion during and after protracted immunosuppressive treatment in type B chronic hepatitis. ( Bessone, F; Fay, OH; Palazzi, J; Rojman, JA; Tanno, H, 1988)
"In 42 patients with chronic active hepatitis (CAH), liver biopsies were subjected to histological study and morphometry before and after prednisolone treatment (21 patients comprising group I) and treatment with a complex of vitamins B1, B6, B12 and C (21 patients comprising group II)."2.66[Evaluation of therapeutic effectiveness of prednisolone in patients with chronic active hepatitis based on the morphometry of liver biopsy specimens]. ( Mansurov, KhKh; Mirodzhov, GK; Mishanina, ZG; Pavlov, VL, 1985)
"Prednisolone peak levels were similar in the three groups."2.65Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects. ( Go, VL; Kluge, D; Uribe, M, 1984)
"Thirty-six patients with biopsy-proved chronic active hepatitis (CAH) were randomized."2.65Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study). ( Jávor, T; Kádas, I; Kerekes, E; Paál, M; Pár, A, 1983)
"Oral prednisolone was started and then tapered after achieving biochemical remission."1.56IgG4-related Autoimmune Hepatitis with a Suspected Drug-induced Etiology. ( Enoki, Y; Hitomi, M; Inoue, N; Kawabata, H; Kawakatsu, Y; Minamikawa, T; Miyata, M; Motoi, S; Okazaki, Y; Sone, D; Ueda, Y; Yamaguchi, K, 2020)
"Liver fibrosis was not coarse, but delicate with severe activity in most patients showing chronic hepatitis defined by our strict criteria."1.48Long-term observation of acute-onset autoimmune hepatitis presenting clinically and radiologically as acute hepatitis. ( Fujiwara, K; Fukuda, Y; Kato, N; Nakano, M; Saito, M; Seza, K; Yasui, S; Yokosuka, O, 2018)
"A nationwide survey of autoimmune hepatitis (AIH) patients was performed in Japan in 2015."1.46Autoimmune hepatitis in Japan: trends in a nationwide survey. ( Abe, M; Arinaga-Hino, T; Fujisawa, T; Kang, JH; Nakamoto, N; Ohira, H; Suzuki, Y; Takahashi, A; Takaki, A; Takikawa, H; Tanaka, A; Torimura, T; Yonemoto, K; Yoshizawa, K; Zeniya, M, 2017)
"Prednisolone treatment normalized coagulopathies associated with chronic idiopathic hepatitis within one week in all 10 dogs that had coagulopathies at initial diagnosis."1.39A retrospective study of oral prednisolone treatment in canine chronic hepatitis. ( Favier, RP; Penning, LC; Poldervaart, JH; Rothuizen, J; van den Ingh, TS, 2013)
"Here we report two patients with severe juvenile dermatomyositis (JDM) complicated with extra musculocutaneous involvement."1.33Severe juvenile dermatomyositis: two patients complicated with extra musculocutaneous involvement. ( Akalin, T; Aslan, MT; Gökben, S; Polat, M; Serdaroğlu, G; Tekgul, H; Tosun, A, 2006)
"We report here a patient with chronic active hepatitis who had no markers for hepatitis viruses and no hyper-gamma-globulinemia, but had high titers of antimitochondrial antibody."1.31A case of autoimmune hepatitis with a high titer of antimitochondrial antibody and normal gamma-globulinemia. ( Gershwin, ME; Mitamura, K; Morizane, T; Onozuka, Y; Shibata, M; Tanaka, A; Uchida, T, 2001)
"To determine whether "autoimmune hepatitis type IIb" should be categorized as a subgroup of autoimmune hepatitis, we conducted a clinicopathological study of 25 adult Japanese patients who were positive for anti-liver/kidney microsome-1 (anti-LKM-1) anti-body and infected with the hepatitis C virus (HCV)."1.30Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis. ( Abe, K; Fuzikawa, H; Hayashi, N; Kako, M; Kawaguchi, N; Kikuchi, K; Kitazawa, E; Kiyosawa, K; Komatsu, T; Miyakawa, H, 1997)
"The entity of autoimmune chronic active hepatitis is unclear, and perhaps it is better defined as steroid-responsive hepatitis."1.29Idiopathic chronic active hepatitis: a diagnostic and therapeutic dilemma. ( Al-Fadda, M; al-Kahtani, K; Ayub, A; Zafar, M, 1994)
"A 37 year old patient with chronic active hepatitis progressing to cirrhosis presented with increasing breathlessness and was found to be hypoxic with finger clubbing."1.29Spontaneous improvement in a patient with the hepatopulmonary syndrome assessed by serial exercise tests. ( Dalton, HR; Fernando, SS; Joseph, A; Saunders, KB, 1994)
"A history of idiopathic thrombocytopenic purpura could be considered a contraindication for alpha-interferon therapy in patients with chronic viral hepatitis."1.29[Exacerbation of an autoimmune thrombocytopenic purpura during treatment with interferon alpha in a woman with chronic viral hepatitis C]. ( Bacq, Y; Barin, F; Degenne, D; Fimbel, B; Gruel, Y; Metman, EH; Sapey, T, 1996)
"We report four cases of acute pneumonitis due either to interferon, or a herbal drug, "Sho-saiko-to", or both in combination, in patients with chronic active hepatitis, focusing on its pathogenesis and response to prednisolone therapy."1.29Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis. ( Abe, Y; Ameshima, S; Ishizaki, T; Ito, S; Kitagawa, M; Kuriyama, M; Nakai, T; Sasaki, F; Shiozaki, K; Takahashi, H, 1996)
"The effectiveness of antiviral treatment on chronic hepatitis B, especially the priority of interferon with steroid withdrawal, was thought to be established through this study."1.28Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model. ( Imazeki, F; Ohto, M; Omata, M; Takano, S; Yokosuka, O, 1992)
"A 41 year old woman developed chronic active hepatitis with prominent cholestasis."1.28Ursodeoxycholic acid therapy in chronic active hepatitis. ( Bateson, MC, 1990)
"Prednisolone, 60 mg/day, was administered initially and the dose was tapered every 2 weeks over the 8 weeks period."1.28Effect of short-term prednisolone therapy in patients with severe chronic type B hepatitis. ( Chung, WK; Kim, HY; Park, CK; Shim, KS; Yoo, JY, 1989)
"Features typical of chronic active hepatitis were observed on examination of the liver biopsy, and both the clinical and histological pictures were unlike those of other possible causes of liver dysfunction, such as chronic rejection, cyclosporine hepatotoxicity, and non-A non-B chronic hepatitis."1.27Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting. ( Calne, R; Neuberger, J; Portmann, B; Williams, R, 1984)
"The term chronic active hepatitis covers aetiologically different conditions with similar histological features."1.27Treatment of chronic active hepatitis and other liver diseases with corticosteroid agents. ( Mackay, IR, 1987)
"In primary biliary cirrhosis, drug-induced hepatitis, and non-hepatic immunological disorders, the production of the three autoantibodies did not directly correlate with liver cell damage."1.27Clinical evaluation of autoantibodies to liver cell membrane specific antigen, liver specific lipoprotein, and Tamm-Horsfall glycoprotein in autoimmune chronic active hepatitis. ( Arima, T; Morichika, S; Nagashima, H, 1987)
"Evidence for autoimmune chronic active hepatitis ab initio included prolonged fever, lymphadenopathy, urticaria, arthralgia, Coombs' positive hemolytic anemia, lymphopenia, a markedly raised level of immunoglobulin G and a positive antinuclear antibody test."1.27'Acute' autoimmune hepatitis. ( Bhathal, PS; Crapper, RM; Frazer, IH; Mackay, IR, 1986)
"Five patients with autoimmune chronic active hepatitis were diagnosed for the first time over the age of 70 years."1.27Chronic active hepatitis in the elderly. ( Selby, CD; Toghill, PJ, 1986)

Research

Studies (97)

TimeframeStudies, this research(%)All Research%
pre-199048 (49.48)18.7374
1990's39 (40.21)18.2507
2000's3 (3.09)29.6817
2010's4 (4.12)24.3611
2020's3 (3.09)2.80

Authors

AuthorsStudies
Bayton, W1
Watson, PJ1
Bexfield, NH1
Kawabata, H1
Kawakatsu, Y1
Inoue, N1
Okazaki, Y1
Sone, D1
Yamaguchi, K1
Ueda, Y1
Hitomi, M1
Miyata, M1
Motoi, S1
Enoki, Y1
Minamikawa, T1
Vuille-Lessard, É1
Montani, M1
Bosch, J1
Semmo, N1
Fujiwara, K1
Fukuda, Y1
Seza, K1
Saito, M1
Yasui, S1
Nakano, M1
Yokosuka, O2
Kato, N1
Favier, RP1
Poldervaart, JH1
van den Ingh, TS1
Penning, LC1
Rothuizen, J1
Nagamura, N1
Ueno, S1
Fujishiro, H1
Oonuma, H1
Takahashi, A1
Arinaga-Hino, T1
Ohira, H1
Torimura, T1
Zeniya, M1
Abe, M1
Yoshizawa, K1
Takaki, A1
Suzuki, Y1
Kang, JH1
Nakamoto, N1
Fujisawa, T1
Yonemoto, K1
Tanaka, A2
Takikawa, H1
GROS, H1
IARTSEVA, AM1
ZEREBTSOV, LA1
ZHEREBTSOV, LA1
MACKAY, IR3
WEIDEN, S1
UNGAR, B1
MATVEEV, AA1
LUPU, NG1
POPESCU, IG1
ZAMFIRESCU-GHEORGHIU, M1
VELICAN, D1
CIOBANU, F1
Tosun, A1
Serdaroğlu, G1
Aslan, MT1
Polat, M1
Akalin, T1
Tekgul, H1
Gökben, S1
Potthoff, A1
Deterding, K1
Trautwein, C1
Flemming, P1
Strassburg, CP1
Manns, MP1
Wedemeyer, H1
Bahr, MJ1
McFarlane, IG1
Hegarty, JE3
McSorley, CG1
McFarlane, BM1
Williams, R6
Idrisova, RS1
Tsoĭ, IG1
Date, A1
Chandy, M1
Pulimood, BM1
Neuberger, J1
Portmann, B4
Calne, R1
Abonyi, M1
Kisfaludy, S1
Szalay, F1
Uribe, M1
Go, VL1
Kluge, D1
Kendrey, G1
László, B1
Pár, A2
Paál, M1
Kádas, I1
Kerekes, E1
Jávor, T1
Vegnente, A1
Larcher, VF1
Mowat, AP2
Thomas, HC1
Brown, D1
Labrooy, J1
Epstein, O1
Liaw, YF3
Chu, CM3
Su, IJ1
Huang, MJ1
Lin, DY1
Chang-Chien, CS1
Eisenburg, J1
Schvarcz, R2
Glaumann, H1
Weiland, O1
Jackson, LD1
Song, E1
Al-Fadda, M1
Zafar, M1
Ayub, A1
al-Kahtani, K1
Glück, T1
Weber, P1
Wiedmann, KH1
Horsmans, Y1
Piret, A1
Brenard, R1
Rahier, J1
Geubel, AP1
Lin, SM2
Chen, TJ2
Chien, RN1
Sheen, IS2
Saunders, KB1
Fernando, SS1
Dalton, HR1
Joseph, A1
Ben-Ari, Z1
Dhillon, AP1
Sherlock, S1
Saeki, R1
Kaneko, S1
Terasaki, S1
Unoura, M1
Ogino, H1
Wakabayashi, T1
Kawara, S1
Nakanuma, Y1
Kobayashi, K2
Payen, JL1
Rabbia, I1
Combis, M1
Voigt, JJ1
Vinel, P1
Pascal, JP1
Thiele, DL1
DuCharme, L1
Cunningham, MR1
Mimms, LT1
Cuthbert, JA1
Lee, WM1
Combes, B1
Bacq, Y1
Sapey, T1
Gruel, Y1
Fimbel, B1
Degenne, D1
Barin, F1
Metman, EH1
Nakajima, M1
Kubota, Y1
Miyashita, N1
Niki, Y1
Matsushima, T1
Manabe, T1
Murakami, C1
Hino, K1
Okazaki, M1
Fujii, K1
Okuda, M1
Hanada, H1
Yamasaki, T1
Okita, K1
Ishizaki, T1
Sasaki, F1
Ameshima, S1
Shiozaki, K1
Takahashi, H1
Abe, Y1
Ito, S1
Kuriyama, M1
Nakai, T1
Kitagawa, M1
Yamamoto, T1
Yokoyama, A1
Kamiyama, T1
Nouchi, T1
Kojima, S1
Murata, N1
Ikeda, T2
Sato, C1
Kanzler, S1
Gerken, G1
Dienes, HP1
Meyer zum Büschenfelde, KH1
Lohse, AW1
Johnson, PJ1
Miyakawa, H1
Kitazawa, E1
Abe, K1
Kawaguchi, N1
Fuzikawa, H1
Kikuchi, K1
Kako, M1
Komatsu, T1
Hayashi, N1
Kiyosawa, K1
Shibata, M1
Morizane, T1
Onozuka, Y1
Uchida, T1
Gershwin, ME1
Mitamura, K1
Niederau, C1
Heintges, T1
Niederau, M1
Stremmel, W1
Strohmeyer, G1
Takano, S1
Omata, M2
Imazeki, F1
Ohto, M2
Lau, JY1
Bird, GL1
Gimson, AE1
Alexander, GJ2
de Man, RA1
Berk, L1
Schalm, SW1
Stijnen, T1
Podymova, SD1
Fei, GZ1
Sylvan, SP1
Hellström, UB1
Yao, GB1
Ryss, EA1
Fishzon-Ryss, IuI1
Zargar, SA1
Thapa, BR1
Sahni, A1
Mehta, S1
Hayasaka, A1
Kohen, H1
Iida, S1
Polus, M1
Lee, SD1
Tong, MJ1
Wu, JC1
Lin, HC1
Tsai, YT1
Lo, KJ1
Egorov, VB1
Gol'zand, IV1
Bateson, MC1
Heigl, F1
Pape, GR1
Bauriedel, G1
Gerbig, H1
Neudert, J1
Zachoval, R1
Wiebecke, B1
Steinbeck, G1
McClements, BM1
Callender, ME1
Itoh, S1
Matsuo, S1
Oda, T1
Marutani, K1
Sasaki, K1
Uchiumi, K1
Yamada, H1
Shimizu, H1
Taniguchi, O1
Okumura, K1
Yoo, JY1
Kim, HY1
Park, CK1
Shim, KS1
Chung, WK1
Giacchino, R2
Facco, F2
Loy, A1
Timitilli, A2
Cirillo, C2
Navone, C2
Ciravegna, B1
Pisani, N1
Iwamoto, H1
Tsuji, H1
Fukui, N1
Watanabe, H1
Nunoi, K1
Murai, K1
Akagi, K1
Fujishima, M1
Yamada, T1
Stellon, AJ2
Uchihara, M1
Daiguji, Y1
Hasumura, Y1
Takeuchi, J1
Tanno, H1
Fay, OH1
Rojman, JA1
Palazzi, J1
Bessone, F1
Sieber, G1
Teichmann, JV1
Möller, B1
Hopf, U1
Giambartolomei, G1
Barigione, G1
Terragna, A1
Imamura, Y1
Hashimoto, N1
Umeda, N1
Yamato, S1
Morishita, K1
Kojima, Y1
Kawamura, N1
Shoda, R1
Matsueda, K1
Shimojo, E1
Webb, A1
Compston, JE1
Hirai, N1
Shimizu, M2
Morioka, T1
Hinoue, Y1
Tanaka, N1
Hattori, N1
Hashimoto, T1
Dakkak, M1
Bennett, JR1
Tokita, H1
Takahashi, Y1
Tanaka, H1
Yasuda, M1
Kojima, M2
Adachi, N1
Yoshida, H1
Mansurov, KhKh2
Asfandiiarova, NS1
Nikolaeva, OS1
Mansurova, FKh1
Rasunova, TKh1
Morichika, S1
Arima, T1
Nagashima, H1
Kumada, H1
Ikeda, K1
Yoshida, A1
Seto, S1
Tsukada, T1
Suzuki, H1
Mayumi, M1
Thomas, PS1
Crapper, RM1
Bhathal, PS1
Frazer, IH1
Selby, CD1
Toghill, PJ1
Nouri-Aria, KT1
Eddleston, AL1
Mirodzhov, GK1
Mishanina, ZG1
Pavlov, VL1
Wiese, M1
Storch, W1
Künzel, R1
Trivedi, P1
Cheeseman, P1
Hegarty, J1
Hoofnagle, JH1
Davis, GL1
Pappas, SC1
Hanson, RG1
Peters, M1
Avigan, MI1
Waggoner, JG1
Jones, EA1
Seeff, LB1
Yamanishi, Y1
Nosaka, Y1
Kawasaki, H1
Hirayama, C1
Ikawa, S1
de Maubeuge, J1
Reding, P1
Tielemans, C1
Dratwa, M1
Van Laethem, Y1
Achten, G1

Reviews

7 reviews available for prednisolone and Hepatitis, Chronic

ArticleYear
T cell subsets in autoimmune and HBV-induced chronic liver disease, HBs antigen carriers with normal histology and primary biliary cirrhosis: a review of the abnormalities and the effects of treatment.
    Journal of clinical immunology, 1982, Volume: 2, Issue:3 Suppl

    Topics: Antibodies, Monoclonal; Autoimmune Diseases; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surfac

1982
Autoimmune hepatitis triggered by administration of an herbal medicine.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:4

    Topics: Autoimmune Diseases; Chemical and Drug Induced Liver Injury; Drug Combinations; Drugs, Chinese Herba

1997
[Chronic hepatitis C: virologic and immunologic aspects and questions of therapy].
    Orvosi hetilap, 1997, Jun-01, Volume: 138, Issue:22 Suppl 1

    Topics: Africa; Antiviral Agents; Asia; Europe; Genotype; Glucocorticoids; Hepacivirus; Hepatitis B Surface

1997
Treatment of chronic viral hepatitis.
    Digestive diseases (Basel, Switzerland), 1991, Volume: 9, Issue:1

    Topics: Acyclovir; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis, Chronic; Humans; Interferons; Prednisol

1991
[Problem of chronic hepatitis (classification, pathogenesis and treatment].
    Klinicheskaia meditsina, 1991, Volume: 69, Issue:6

    Topics: Autoimmune Diseases; Azathioprine; Chronic Disease; Hepatitis; Hepatitis B; Hepatitis B Antibodies;

1991
[Chronic hepatitis--various aspects of the problem].
    Klinicheskaia meditsina, 1991, Volume: 69, Issue:9

    Topics: Antiviral Agents; Azathioprine; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Hepatit

1991
[Chronic active autoimmune hepatitis: literature review].
    Revue medicale de Liege, 1991, Volume: 46, Issue:9

    Topics: Autoantibodies; Autoimmune Diseases; Azathioprine; Drug Therapy, Combination; Hepatitis, Chronic; Hu

1991

Trials

15 trials available for prednisolone and Hepatitis, Chronic

ArticleYear
Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Acta physiologica Hungarica, 1984, Volume: 64, Issue:3-4

    Topics: Adult; Aged; Benzopyrans; Catechin; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis,

1984
Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects.
    Journal of clinical gastroenterology, 1984, Volume: 6, Issue:4

    Topics: Adult; Albumins; Bilirubin; Female; Hepatitis, Chronic; Humans; In Vitro Techniques; Kinetics; Male;

1984
Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Acta medica Hungarica, 1983, Volume: 40, Issue:1

    Topics: Benzopyrans; Catechin; Drug Therapy, Combination; Hepatitis B; Hepatitis, Chronic; Humans; Liver Fun

1983
Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial.
    Journal of hepatology, 1994, Volume: 20, Issue:2

    Topics: Adult; Alanine Transaminase; DNA, Viral; Drug Therapy, Combination; Ethnicity; Hepatitis B; Hepatiti

1994
Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    The European journal of medicine, 1992, Volume: 1, Issue:7

    Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; DNA, Viral; Drug Therapy, Combination; Female;

1992
Chronic posttransfusion non-A, non-B hepatitis and autoimmune chronic active hepatitis-aspects on treatment, prognosis and relation to hepatitis C virus.
    Scandinavian journal of infectious diseases. Supplementum, 1991, Volume: 79

    Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Chronic Disease; Female; Follow-Up Studies; Hepaciviru

1991
A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B.
    Journal of hepatology, 1991, Volume: 12, Issue:2

    Topics: Adult; China; DNA, Viral; Double-Blind Method; Drug Administration Schedule; Female; Hematologic Tes

1991
[Chronic active hepatitis B in children: effects of various methods of treatment].
    Pediatriia, 1991, Issue:2

    Topics: Adjuvants, Immunologic; Child; Female; Hepatitis B; Hepatitis, Chronic; Humans; Immunologic Deficien

1991
D-penicillamine therapy in patients with HBsAg-negative chronic active hepatitis and major prednisolone-induced adverse effects.
    Journal of hepatology, 1990, Volume: 11, Issue:3

    Topics: Adult; Aged; Azathioprine; Dose-Response Relationship, Drug; Female; Hepatitis B Surface Antigens; H

1990
Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis.
    Lancet (London, England), 1985, Mar-23, Volume: 1, Issue:8430

    Topics: Adult; Aged; Autoimmune Diseases; Azathioprine; Clinical Trials as Topic; Drug Therapy, Combination;

1985
Treatment of chronic type B hepatitis in Southeast Asia.
    The American journal of medicine, 1988, Aug-29, Volume: 85, Issue:2A

    Topics: Asia, Southeastern; Clinical Trials as Topic; Female; Hepatitis B; Hepatitis, Chronic; Humans; Immun

1988
HBeAg/anti-HBe seroconversion during and after protracted immunosuppressive treatment in type B chronic hepatitis.
    Journal of medical virology, 1988, Volume: 25, Issue:1

    Topics: Azathioprine; Clinical Trials as Topic; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens;

1988
Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7 Suppl 3

    Topics: Adolescent; Alanine Transaminase; Child; Child, Preschool; Clinical Trials as Topic; Combined Modali

1988
[Evaluation of therapeutic effectiveness of prednisolone in patients with chronic active hepatitis based on the morphometry of liver biopsy specimens].
    Terapevticheskii arkhiv, 1985, Volume: 57, Issue:2

    Topics: Ascorbic Acid; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B;

1985
A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial.
    Annals of internal medicine, 1986, Volume: 104, Issue:1

    Topics: Adult; Alanine Transaminase; DNA-Directed DNA Polymerase; Double-Blind Method; Drug Administration S

1986

Other Studies

75 other studies available for prednisolone and Hepatitis, Chronic

ArticleYear
Prednisolone therapy for chronic hepatitis in English springer spaniels: a prospective study of 12 cases.
    The Veterinary record, 2020, Jun-13, Volume: 186, Issue:18

    Topics: Animals; Dog Diseases; Dogs; Female; Hepatitis, Chronic; Male; Prednisolone; Prospective Studies; Tr

2020
IgG4-related Autoimmune Hepatitis with a Suspected Drug-induced Etiology.
    Internal medicine (Tokyo, Japan), 2020, Volume: 59, Issue:11

    Topics: Aged; Anti-Inflammatory Agents; Cholagogues and Choleretics; Hepatitis, Autoimmune; Hepatitis, Chron

2020
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    Journal of autoimmunity, 2021, Volume: 123

    Topics: 2019-nCoV Vaccine mRNA-1273; Aged; Autoantibodies; Azathioprine; Carcinoma, Transitional Cell; Causa

2021
Long-term observation of acute-onset autoimmune hepatitis presenting clinically and radiologically as acute hepatitis.
    Hepatology international, 2018, Volume: 12, Issue:2

    Topics: Acute Disease; Antiviral Agents; Dexamethasone; Female; Follow-Up Studies; Hepatitis; Hepatitis, Aut

2018
A retrospective study of oral prednisolone treatment in canine chronic hepatitis.
    The veterinary quarterly, 2013, Volume: 33, Issue:3

    Topics: Animals; Dog Diseases; Dogs; Female; Hepatitis, Chronic; Male; Netherlands; Prednisolone; Retrospect

2013
Hepatitis associated with hypereosinophilia suspected to be caused by HES that also presented with the pathological features of IgG4-related disease.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:2

    Topics: Alanine Transaminase; Alkaline Phosphatase; Antibodies, Antineutrophil Cytoplasmic; Aspartate Aminot

2014
Autoimmune hepatitis in Japan: trends in a nationwide survey.
    Journal of gastroenterology, 2017, Volume: 52, Issue:5

    Topics: Acute Disease; Adult; Age Distribution; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; D

2017
[Critical comments on the glycocorticoid therapy of chronic hepatitis].
    Medizinische Klinik, 1963, Apr-26, Volume: 58

    Topics: Hepatitis; Hepatitis A; Hepatitis, Chronic; Methylprednisolone; Prednisolone; Prednisone

1963
[Chronic hepatitis as a result of Botkin's disease and prednisolone therapy].
    Terapevticheskii arkhiv, 1963, Volume: 35

    Topics: Hepatitis; Hepatitis A; Hepatitis, Chronic; Humans; Liver Cirrhosis; Prednisolone

1963
[Use of prednisolone in chronic hepatitis and liver cirrhosis].
    Klinicheskaia meditsina, 1962, Volume: 40

    Topics: Hepatitis; Hepatitis A; Hepatitis, Chronic; Humans; Liver Cirrhosis; Prednisolone

1962
[COMPLICATIONS DURING PREDNISOLONE THERAPY OF CHRONIC HEPATITIS AND LIVER CIRRHOSIS].
    Terapevticheskii arkhiv, 1963, Volume: 35

    Topics: Adolescent; Adrenocortical Hyperfunction; Cardiovascular System; Dyspepsia; Geriatrics; Glycosuria;

1963
TREATMENT OF ACTIVE CHRONIC HEPATITIS AND LUPOID HEPATITIS WITH 6-MERCAPTOPURINE AND AZOTHIOPRINE.
    Lancet (London, England), 1964, Apr-25, Volume: 1, Issue:7339

    Topics: Adolescent; Anemia; Anemia, Pernicious; Antineoplastic Agents; Autoimmune Diseases; Azathioprine; Cl

1964
[ON THE STUDY OF PATHOGENESIS OF RECURRENT EPIDEMIC HEPATITIS IN PATIENTS UNDERGOING HORMONE THERAPY].
    Klinicheskaia meditsina, 1965, Volume: 43

    Topics: Communicable Diseases; Drug Therapy; Hepatitis; Hepatitis A; Hepatitis, Chronic; Humans; Prednisolon

1965
[Therapeutic investigations in experimental toxic chronic hepatitis].
    Studii si cercetari de medicina interna, 1961, Volume: 2

    Topics: Chemical and Drug Induced Liver Injury; Corrinoids; Cytochromes; Hepatitis; Hepatitis, Chronic; Pred

1961
Severe juvenile dermatomyositis: two patients complicated with extra musculocutaneous involvement.
    Rheumatology international, 2006, Volume: 26, Issue:11

    Topics: Adolescent; Child; Dermatomyositis; Hepatitis, Chronic; Humans; Lung; Lung Diseases, Interstitial; M

2006
Steroid treatment for severe acute cryptogenic hepatitis.
    Zeitschrift fur Gastroenterologie, 2007, Volume: 45, Issue:1

    Topics: Acute Disease; Adult; Female; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Male; Mercaptopu

2007
Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis.
    Lancet (London, England), 1984, Oct-27, Volume: 2, Issue:8409

    Topics: Adolescent; Adult; Aged; Autoantibodies; Autoimmune Diseases; Azathioprine; Clinical Enzyme Tests; F

1984
[Indicators of cellular immunity in various types of treatment of children with chronic hepatitis B].
    Pediatriia, 1984, Issue:8

    Topics: Adjuvants, Immunologic; Adolescent; Child; Chronic Disease; Hepatitis B; Hepatitis, Chronic; Humans;

1984
Filarial chyluria with opportunistic infections.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 1983, Volume: 77, Issue:1

    Topics: Azathioprine; Candidiasis; Chyle; Cryptococcosis; Filariasis; Hepatitis, Chronic; Humans; Lymphopeni

1983
Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting.
    Transplantation, 1984, Volume: 37, Issue:4

    Topics: Adult; Autoimmune Diseases; Azathioprine; Cyclosporins; Female; Hepatitis, Chronic; Humans; Liver Tr

1984
[Chronic active giant cell hepatitis in a young adult].
    Morphologiai es igazsagugyi orvosi szemle, 1984, Volume: 24, Issue:4

    Topics: Adolescent; Azathioprine; Hepatitis, Chronic; Humans; Liver; Male; Microscopy, Electron; Mitochondri

1984
Duration of chronic active hepatitis and the development of cirrhosis.
    Archives of disease in childhood, 1984, Volume: 59, Issue:4

    Topics: Adolescent; Aspartate Aminotransferases; Autoantibodies; Azathioprine; Bilirubin; Child; Child, Pres

1984
Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.
    Gastroenterology, 1983, Volume: 84, Issue:2

    Topics: Adult; Alanine Transaminase; Antibody Formation; Azathioprine; Biopsy; Female; Hepatitis B; Hepatiti

1983
[Interferon or C virus-induced autoimmune chronic hepatitis? Report of personal observations and review of the literature].
    Fortschritte der Medizin, 1994, Aug-30, Volume: 112, Issue:24

    Topics: Adult; Autoantibodies; Biopsy; Chemical and Drug Induced Liver Injury, Chronic; Hepacivirus; Hepatit

1994
Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis.
    Journal of hepatology, 1993, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Azathioprine; Biopsy; Drug Therapy, Combination; Femal

1993
Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis.
    Gut, 1995, Volume: 36, Issue:3

    Topics: Adolescent; Azathioprine; Cyclosporine; Drug Administration Schedule; Drug Resistance, Multiple; Hep

1995
Idiopathic chronic active hepatitis: a diagnostic and therapeutic dilemma.
    Journal of clinical gastroenterology, 1994, Volume: 19, Issue:4

    Topics: Autoimmune Diseases; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Hepatitis, Ch

1994
[Hepatitis-B-associated vasculitis. Clinical course with glucocorticoid and alpha-interferon therapy].
    Deutsche medizinische Wochenschrift (1946), 1994, Oct-14, Volume: 119, Issue:41

    Topics: Adult; Female; Hepatitis B; Hepatitis, Chronic; Humans; Interferon-alpha; Prednisolone; Vasculitis

1994
Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report.
    Journal of hepatology, 1994, Volume: 21, Issue:2

    Topics: Autoimmune Diseases; Azathioprine; Drug Therapy, Combination; Female; Hepatitis, Chronic; Humans; Im

1994
Spontaneous improvement in a patient with the hepatopulmonary syndrome assessed by serial exercise tests.
    Thorax, 1994, Volume: 49, Issue:7

    Topics: Adult; Azathioprine; Exercise Test; Hepatitis, Chronic; Humans; Hypoxia; Liver Cirrhosis; Lung Disea

1994
Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis.
    Hepatology (Baltimore, Md.), 1993, Volume: 18, Issue:1

    Topics: Actins; Adult; Alkaline Phosphatase; Antibodies, Antinuclear; Autoimmune Diseases; Bile Ducts, Intra

1993
Mixed types of chronic active hepatitis and primary biliary cirrhosis associated with the anti-phospholipid antibody syndrome: a case report.
    Hepato-gastroenterology, 1993, Volume: 40, Issue:5

    Topics: Adult; Antiphospholipid Syndrome; Female; Hepatitis, Chronic; Humans; Liver Cirrhosis, Biliary; Pred

1993
[Disclosure of autoimmune hepatitis by interferon].
    Gastroenterologie clinique et biologique, 1993, Volume: 17, Issue:5

    Topics: Adult; Autoimmune Diseases; Female; Hepatitis, Chronic; Humans; Interferon Type I; Prednisolone; Rec

1993
Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Autoantibodies; Autoimmune Diseases; Base

1996
[Exacerbation of an autoimmune thrombocytopenic purpura during treatment with interferon alpha in a woman with chronic viral hepatitis C].
    Gastroenterologie clinique et biologique, 1996, Volume: 20, Issue:3

    Topics: Adult; Antiviral Agents; Female; Glucocorticoids; Hepatitis C; Hepatitis, Chronic; Humans; Immunoglo

1996
Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C.
    Internal medicine (Tokyo, Japan), 1996, Volume: 35, Issue:5

    Topics: Aged; Anti-Inflammatory Agents; Biomarkers; Hepatitis C; Hepatitis, Chronic; Humans; Immunologic Fac

1996
Hepatitis B virus carrier status linked to autoimmune hepatitis.
    Internal medicine (Tokyo, Japan), 1996, Volume: 35, Issue:6

    Topics: Adult; Alanine Transaminase; Autoantibodies; Autoimmune Diseases; Azathioprine; Biomarkers; Carrier

1996
Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis.
    The European respiratory journal, 1996, Volume: 9, Issue:12

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Drug Therapy, Combination; Drugs,

1996
Hypergammaglobulinemic purpura associated with Sjögren's syndrome and chronic C type hepatitis.
    The Journal of dermatology, 1997, Volume: 24, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Antinuclear; Cryoglobulins; Female; H

1997
Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases.
    Zeitschrift fur Gastroenterologie, 1997, Volume: 35, Issue:7

    Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; Autoimmune Diseases; Cyclophosphamide; Dose-Respons

1997
Treatment of autoimmune hepatitis.
    Gut, 1997, Volume: 41, Issue:1

    Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Female; Hepatitis, Chronic; Humans; Imm

1997
Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis.
    Journal of gastroenterology, 1997, Volume: 32, Issue:6

    Topics: Adult; Aged; Autoantibodies; Biopsy; Blotting, Western; Female; Fluorescent Antibody Technique, Indi

1997
A case of autoimmune hepatitis with a high titer of antimitochondrial antibody and normal gamma-globulinemia.
    Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:7

    Topics: Aged; Autoantibodies; Cholagogues and Choleretics; Female; gamma-Globulins; Glucocorticoids; Hepatit

2001
Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model.
    Digestive diseases and sciences, 1992, Volume: 37, Issue:11

    Topics: Antiviral Agents; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Stu

1992
Treatment of HBV reactivation after withdrawal of immunosuppression.
    Lancet (London, England), 1991, Mar-30, Volume: 337, Issue:8744

    Topics: Chemical and Drug Induced Liver Injury, Chronic; Hepatitis B; Hepatitis B virus; Hepatitis, Chronic;

1991
IgM anti-preS2 monitoring during combined corticosteroid/interferon-alpha 2b therapy in chronic hepatitis B.
    Liver, 1991, Volume: 11, Issue:6

    Topics: Adult; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Hepatitis B; Hepatitis B Antibo

1991
Kayser-Fleischer like ring in autoimmune chronic active hepatitis.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 1991, Volume: 10, Issue:3

    Topics: Autoimmune Diseases; Child; Copper; Cornea; Diagnosis, Differential; Hepatitis, Chronic; Hepatolenti

1991
[Cases of chronic hepatitis which showed clear changes of serum levels of 7S-collagen in response to steroid and interferon therapy].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1991, Volume: 88, Issue:8

    Topics: Aged; Autoimmune Diseases; Chronic Disease; Collagen; Female; Hepatitis; Hepatitis B; Hepatitis, Chr

1991
Ursodeoxycholic acid therapy in chronic active hepatitis.
    Postgraduate medical journal, 1990, Volume: 66, Issue:779

    Topics: Adult; Autoimmune Diseases; Azathioprine; Chronic Disease; Drug Therapy, Combination; Female; Hepati

1990
[A 65-year old jaundiced patient with weight loss, fever and sicca syndrome].
    Der Internist, 1990, Volume: 31, Issue:9

    Topics: Aged; Autoimmune Diseases; Biopsy; Female; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis; Liver

1990
Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal.
    Digestive diseases and sciences, 1990, Volume: 35, Issue:9

    Topics: Adult; Alanine Transaminase; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis, Chr

1990
Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
    Journal of hepatology, 1986, Volume: 3 Suppl 2

    Topics: Antiviral Agents; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens;

1986
Leu-1(CD5) B cell subpopulation in patients with various liver diseases--special reference to hepatitis B virus carrier and to changes caused by prednisolone therapy.
    International archives of allergy and applied immunology, 1988, Volume: 87, Issue:4

    Topics: Adult; Aged; Antigens, Differentiation; B-Lymphocytes; Carrier State; CD5 Antigens; Female; Flow Cyt

1988
Effect of short-term prednisolone therapy in patients with severe chronic type B hepatitis.
    The Korean journal of internal medicine, 1989, Volume: 4, Issue:1

    Topics: Adolescent; Adult; Biopsy; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surf

1989
[Reactivation of virus replication during immunosuppressive therapy in children with chronic hepatitis B].
    Bollettino dell'Istituto sieroterapico milanese, 1989, Volume: 68, Issue:1

    Topics: Azathioprine; Child; DNA Replication; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepat

1989
[A case of mixed connective tissue disease associated with chronic active hepatitis].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1989, Volume: 86, Issue:6

    Topics: Female; Hepatitis, Chronic; Humans; Middle Aged; Mixed Connective Tissue Disease; Prednisolone

1989
Immunological mechanisms of corticosteroid therapy in chronic active hepatitis: analysis of peripheral blood suppressor T-cell and interleukin 2 activities.
    Clinical immunology and immunopathology, 1988, Volume: 48, Issue:3

    Topics: Female; Hepatitis, Chronic; Humans; Immune Tolerance; In Vitro Techniques; Interleukin-2; Lymphocyte

1988
Abnormalities of B cell activation and immunoregulation in patients with chronic inflammatory liver diseases.
    Immunobiology, 1988, Volume: 178, Issue:3

    Topics: Antibody Formation; Autoimmune Diseases; B-Lymphocytes; Cells, Cultured; Hemolytic Plaque Technique;

1988
[A case of primary biliary cirrhosis-chronic active hepatitis overlapping syndrome with improved transaminase levels by steroid treatment].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1988, Volume: 85, Issue:7

    Topics: Female; Hepatitis, Chronic; Humans; Liver Cirrhosis, Biliary; Middle Aged; Prednisolone; Syndrome; T

1988
Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis.
    Gut, 1988, Volume: 29, Issue:3

    Topics: Adult; Aged; Bone and Bones; Bone Resorption; Female; Hepatitis, Chronic; Humans; Middle Aged; Osteo

1988
Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy.
    Liver, 1988, Volume: 8, Issue:3

    Topics: 2',5'-Oligoadenylate Synthetase; Adult; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hep

1988
Chronic active hepatitis.
    Journal of clinical gastroenterology, 1988, Volume: 10, Issue:4

    Topics: Aged; Dose-Response Relationship, Drug; Female; Hepatitis, Chronic; Humans; Prednisolone

1988
[Back-ground factors which affect the outcome of steroid withdrawal therapy in patients with chronic type B hepatitis--statistical evaluation of the importance of the mode of HBV transmission].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1987, Volume: 84, Issue:12

    Topics: Adolescent; Adult; Alanine Transaminase; Child; Female; Follow-Up Studies; Hepatitis B; Hepatitis B

1987
[Immunocorrective therapy of patients with chronic active liver diseases of a viral nature].
    Terapevticheskii arkhiv, 1987, Volume: 59, Issue:2

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Azathioprine; Female; Hepatitis B; Hepatitis, Chronic; Hu

1987
Treatment of chronic active hepatitis and other liver diseases with corticosteroid agents.
    The Medical journal of Australia, 1987, Apr-06, Volume: 146, Issue:7

    Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Hepatitis, Alcoholic; Hepatitis, Chronic

1987
Clinical evaluation of autoantibodies to liver cell membrane specific antigen, liver specific lipoprotein, and Tamm-Horsfall glycoprotein in autoimmune chronic active hepatitis.
    Gastroenterologia Japonica, 1987, Volume: 22, Issue:1

    Topics: Adult; Aged; Antigens, Surface; Autoantibodies; Autoantigens; Autoimmune Diseases; Enzyme-Linked Imm

1987
Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B.
    Japanese journal of medicine, 1987, Volume: 26, Issue:2

    Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; DNA-Directed DNA Polymerase; Female; Follo

1987
Prednisolone causing amelioration of both vitiligo and chronic active hepatitis.
    British journal of hospital medicine, 1987, Volume: 38, Issue:5

    Topics: Hepatitis, Chronic; Humans; Male; Middle Aged; Prednisolone; Vitiligo

1987
'Acute' autoimmune hepatitis.
    Digestion, 1986, Volume: 34, Issue:3

    Topics: Adult; Autoimmune Diseases; Female; Hepatitis, Chronic; Humans; Liver; Prednisolone; Time Factors

1986
Chronic active hepatitis in the elderly.
    Age and ageing, 1986, Volume: 15, Issue:6

    Topics: Aged; Autoimmune Diseases; Azathioprine; Biopsy; Female; Hepatitis, Chronic; Humans; Male; Prednisol

1986
IgG production in 'autoimmune' chronic active hepatitis. Effect of prednisolone on T and B lymphocyte function.
    Clinical and experimental immunology, 1985, Volume: 61, Issue:2

    Topics: Adult; Aged; Autoimmune Diseases; B-Lymphocytes; Cells, Cultured; Female; Hepatitis, Chronic; Humans

1985
[Virus-associated chronic autoimmune aggressive hepatitis (HBsAg seronegative) with pronounced diarrhea].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1985, Jul-15, Volume: 40, Issue:14

    Topics: Adolescent; Autoimmune Diseases; Azathioprine; Biopsy; Complement System Proteins; Diarrhea; Fluores

1985
Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis.
    European journal of clinical investigation, 1985, Volume: 15, Issue:2

    Topics: Adolescent; Adult; Aged; Aging; Azathioprine; Child; Child, Preschool; Hepatitis, Chronic; Humans; I

1985
Sterol and bile acid metabolism after short-term prednisolone treatment in patients with chronic active hepatitis.
    Gastroenterologia Japonica, 1985, Volume: 20, Issue:3

    Topics: Adolescent; Adult; Bile Acids and Salts; Cholesterol; Female; Hepatitis, Chronic; Humans; Male; Midd

1985
[Cutaneous vasculitis associated with chronic hepatitis: 2 cases].
    Dermatologica, 1985, Volume: 171, Issue:5

    Topics: Azathioprine; Cryoglobulinemia; Female; Glomerulonephritis; Hepatitis, Chronic; Humans; Middle Aged;

1985